期刊文献+

鲍曼不动杆菌对β-内酰胺类抗生素耐药机制的研究进展 被引量:28

Research progress of mechanisms of Acinetobacter baumannii resistance to β-lactam antibiotics
下载PDF
导出
摘要 鲍曼不动杆菌是一种不发酵葡萄糖的革兰阴性球杆菌,近年来临床检出率呈上升趋势,是医院内感染中分离的重要病原菌。鲍曼不动杆菌由于其生存力强、耐药谱广及耐药率高的特点引起了广泛地关注。其耐药机制主要包括产生β-内酰胺酶、青霉素结合蛋白改变、外膜通透性降低和主动外排增强。该文对鲍曼不动杆菌耐β-内酰胺类抗生素机制,尤其是对外膜孔蛋白和主动外排系统机制进行了详细综述。 Acinetobacter baumannii, a glucose-nonfermentative gram-negative coccobacillus, is an important pathogen isolated in nosocomial infections, and the clinical detection rate has been increasing in recent years. Acinetobacter baumannii attracts widespread attention due to strong viability, broad resistance spectrum and high rate of drug resistance. The resistance mechanisms include the production of β-lactamases, alterations in penicillin-binding proteins, decreased outer membrane permeability and overexpression of active efflux pumps. The mechanisms of Acinetobacter baumannii resistance to β-lactam antibiotics, especially those of the outer membrane porin and active efflux system are reviewed in this paper.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2010年第1期98-103,共6页 Journal of Shanghai Jiao tong University:Medical Science
关键词 鲍曼不动杆菌 碳青霉烯类耐药 Β-内酰胺类抗生素 耐药机制 Acinetobacter baumannii carbapenem-resistant β-lactam antibiotics resistance mechanisms
  • 相关文献

参考文献35

  • 1Coelho JM, Turton JF, Kaufmann ME, et al. Occurrence of earba- penem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England[J].J Clin Microbiol, 2006, 44 (10) : 3623 -3627.
  • 2陈升汶,吴伟元,傅应云,谢守霞,何林.鲍曼不动杆菌对碳青霉烯类抗生素耐药性研究[J].中国抗感染化疗杂志,2003,3(1):38-40. 被引量:21
  • 3汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,简翠,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华.2008年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2009,9(5):321-329. 被引量:423
  • 4Brown S, Amyes SG. The sequences of seven class D B-1actamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents[J]. Clin Microbiol Infect, 2005, 11 (4) : 326 - 329.
  • 5Chen CH, Young TG, Huang CC. Predictive biomarkers for drugresistant Acinetobacter baumannii isolates with bla TEM-1, AmpC- type bla and integrase 1 genotypes[ J]. J Microbiol Immunol Infect, 2006, 39 (5) : 372 - 379.
  • 6Endimiani A, Luzzaro F, Migliavacca R, et al. Spread in Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase[J]. Antimicrob Agents Chemother, 2007, 51 (6) : 2211 - 2214.
  • 7Naiemi NA, Duim B, Savelkoul PH, et al. Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology[ J]. J Clin Microbiel, 2005, 43(9) : 4862 -4864.
  • 8Nagano N, Nagano Y, Cordevant C, et al. Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward [ J ]. J Clin Microbiol, 2004, 42 (9) : 3978 -3984.
  • 9Tsakris A, Ikonomidis A, Pournaras S, et al. VIM-I Metallo-β- lactamase in Acinetobacter baumannii[ J]. Emerg Infect Dis, 2006, 12 (6) : 981 -983.
  • 10Jones RN, Biedenbach DJ, Sader HS, et al. Emerging epidemic of metallo-β-1actamase-mediated resistances [ J ]. Diagn Microbiol Infect Dis, 2005, 51(2) : 77 -84.

二级参考文献14

  • 1王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 2Clinical and I.aboratory Standards Institute(CLSI). Perform ance standards for Antimicrobial susceptibility testing[S]. M100-S17, 2007.
  • 3Clinical and Laboratory Standards Institute (CLSI). Perform anee standards for Antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 4Bratu S, I.andman D, Haag R, et al. Rapid spread of carbapenem resistant Klebsiella pneumoniae in New York City: anew threat to our antibiotic armamentarium[J]. Arch Int Meal.2005,165(12) :1430-1435.
  • 5Endimiani A, Hujer AM, Perez F, et al. Characterization of blaKPC containing Klebsiella pneumoniae isolates detected in different institutions in the eastern USA [J]. J Antimierob Chemother, 2009, 63(3):427-437.
  • 6Jeon BC, Jeong SH, Bae IK, et al. Investigation of a nosocomial outbreak of imipenem resistant Acinetobacter baumannii producing the OXA- 23 β- lactamase in Korea[J]. J Clin Microbiol, 2005, 43(5):2241 -2245.
  • 7NaasT, LevyM, HirschauerC, et al. Outbreak ofcarbapen em resistant Acinetobacter baumannii producing the carbap enemase OXA- 23 in a tertiary care hospital of Pepcete, French Polynesta[J]. J Clin Mierohiol, 2005, 43 (9) : 4826- 4829.
  • 8Waites KB, Dully LB, Dowzicky MJ. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and invitro activity of tigecycline, a new glycylcycline antimicrobial[J]. Antimicrob Agents Chemother, 2006,50(10):3479- 3484.
  • 9Souli M, Kontopidou FV, Koratzanis E, et al. lnvitro activity of tigecycline against multiple-drug resistant, including pan resistant, Gram negative and Gram-positive clinical isolates from Greek hospitals[J]. Antimicrob Agents Chemother, 2006.50(9) :3166- 3169.
  • 10Gordon NC, Warehan, DW. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline [J]. J Antimicrob Chemother, 2009, 63(4) :775-780.

共引文献442

同被引文献242

引证文献28

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部